SCHEMBL440764

SCHEMBL440764

Cn1cc(-c2ccccc2)nc1[C@H]1CC[C@H](C(=O)NCCN)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.42
ADORA3 P0DMS8 2/20 0.41
ADORA2A P29274 2/20 0.41
ADORA1 P30542 2/20 0.41
TSHR P16473 1/20 0.41
MTNR1A P48039 3/20 0.41
MTNR1B P49286 3/20 0.41
DRD3 P35462 2/20 0.40
DRD2 P14416 2/20 0.40
PDE10A Q9Y233 4/20 0.40
CYP2C19 P33261 1/20 0.39
HTR1A P08908 1/20 0.39
DRD4 P21917 1/20 0.39
NPC1 O15118 1/20 0.39
USP2 O75604 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL440765 1.00 KDM4E (0.42) KDM4EADORA3ADORA2AADORA1TSHR
SCHEMBL440139 0.80 TDP1 (0.49) ADORA3ADORA2AADORA1PDE10ANPC1
SCHEMBL407247 0.80 TDP1 (0.49) ADORA3ADORA2AADORA1PDE10ANPC1
SCHEMBL440507 0.77 DGAT1 (0.50)
SCHEMBL440508 0.77 DGAT1 (0.50)
SCHEMBL440346 0.71 KCNH2 (0.43) ADORA3ADORA2AADORA1MTNR1AMTNR1B
SCHEMBL440345 0.71 KCNH2 (0.43) ADORA3ADORA2AADORA1MTNR1AMTNR1B
SCHEMBL25317065 0.68 PTGS1 (0.41) KDM4EPDE10ANPC1ALDH1A1HPGD
Hydrochloric Acid SCHEMBL439362 0.68 MC4R (0.51) MTNR1AMTNR1BNPC1USP2ALDH1A1
Hydrochloric Acid SCHEMBL439363 0.68 MC4R (0.51) MTNR1AMTNR1BNPC1USP2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120065196-A1 AMIDE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-15 US disclosed
WO-2008011130-A2 AMIDE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120065196-A1 AMIDE COMPOUNDS DGAT2, DGAT1, DLAT KDM4E 2452/4885ADORA3 2266/4885ADORA2A 1611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.